Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects.

Sciacqua A, Cimellaro A, Mancuso L, Miceli S, Cassano V, Perticone M, Fiorentino TV, Andreozzi F, Succurro E, Sesti G, Perticone F.

Nutrients. 2020 Feb 5;12(2). pii: E412. doi: 10.3390/nu12020412.

2.

Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality.

André S, Andreozzi F, Van Overstraeten C, Ben Youssef S, Bold I, Carlier S, Gruwez A, Bruyneel AV, Bruyneel M.

Respir Res. 2020 Jan 29;21(1):35. doi: 10.1186/s12931-020-1284-7.

3.

Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance.

Succurro E, Pedace E, Andreozzi F, Papa A, Vizza P, Fiorentino TV, Perticone F, Veltri P, Cascini GL, Sesti G.

Diabetes Care. 2020 Mar;43(3):669-676. doi: 10.2337/dc19-1975. Epub 2020 Jan 23.

PMID:
31974102
4.

HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: A longitudinal study.

Fiorentino TV, Succurro E, Marini MA, Pedace E, Andreozzi F, Perticone M, Sciacqua A, Perticone F, Sesti G.

Diabetes Metab Res Rev. 2020 Jan 10:e3289. doi: 10.1002/dmrr.3289. [Epub ahead of print]

PMID:
31922637
5.

Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage.

Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Sesti G.

BMJ Open Diabetes Res Care. 2019 Nov 13;7(1):e000911. doi: 10.1136/bmjdrc-2019-000911. eCollection 2019.

6.

Are Circulating Mg2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes?

Spiga R, Mannino GC, Mancuso E, Averta C, Paone C, Rubino M, Sciacqua A, Succurro E, Perticone F, Andreozzi F, Sesti G.

Nutrients. 2019 Oct 14;11(10). pii: E2460. doi: 10.3390/nu11102460.

7.

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.

Cardone C, Martinelli E, Troiani T, Sforza V, Avallone A, Nappi A, Montesarchio V, Andreozzi F, Biglietto M, Calabrese F, Bordonaro R, Cordio S, Bregni G, Febbraro A, Garcia-Carbonero R, Feliu J, Cervantes A, Ciardiello F.

ESMO Open. 2019 Aug 16;4(4):e000519. doi: 10.1136/esmoopen-2019-000519. eCollection 2019.

8.

Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas.

Fiorentino TV, Casiraghi F, Davalli AM, Finzi G, La Rosa S, Higgins PB, Abrahamian GA, Marando A, Sessa F, Perego C, Guardado-Mendoza R, Kamath S, Ricotti A, Fiorina P, Daniele G, Paez AM, Andreozzi F, Bastarrachea RA, Comuzzie AG, Gastaldelli A, Chavez AO, Di Cairano ES, Frost P, Luzi L, Dick EJ, Halff GA, DeFronzo RA, Folli F.

JCI Insight. 2019 Oct 17;4(20). pii: 93091. doi: 10.1172/jci.insight.93091.

9.

African ethnicity is associated with a higher prevalence of diabetes in obstructive sleep apnea patients: results of a retrospective analysis.

Andreozzi F, Van Overstraeten C, Ben Youssef S, Bold I, Carlier S, Gruwez A, André S, Bruyneel AV, Bruyneel M.

Sleep Breath. 2019 Aug 14. doi: 10.1007/s11325-019-01912-5. [Epub ahead of print]

PMID:
31410809
10.

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.

Mannino GC, Pezzilli S, Averta C, Fuoco A, Spiga R, Mancuso E, Di Fatta C, Perticone F, Prudente S, Trischitta V, Andreozzi F, Sesti G.

Cardiovasc Diabetol. 2019 Aug 13;18(1):102. doi: 10.1186/s12933-019-0906-1.

11.

Individuals With Prediabetes Display Different Age-Related Pathophysiological Characteristics.

Fiorentino TV, Pedace E, Succurro E, Andreozzi F, Perticone M, Sciacqua A, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2911-2924. doi: 10.1210/jc.2018-02610.

PMID:
30848793
12.

Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients.

Sciacqua A, Perticone M, Miceli S, Pinto A, Cassano V, Succurro E, Andreozzi F, Hribal ML, Sesti G, Perticone F.

Endocrine. 2019 Jun;64(3):525-535. doi: 10.1007/s12020-019-01873-5. Epub 2019 Feb 21.

PMID:
30790176
13.

Electrolyte Disorders as Triggers for Takotsubo Cardiomyopathy.

Andreozzi F, Cuminetti G, Karmali R, Kamgang P.

Eur J Case Rep Intern Med. 2018 Apr 24;5(4):000760. doi: 10.12890/2018_000760. eCollection 2018.

14.

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine.

Mannino GC, Andreozzi F, Sesti G.

Diabetes Metab Res Rev. 2019 Mar;35(3):e3109. doi: 10.1002/dmrr.3109. Epub 2019 Jan 7. Review.

15.

One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI study.

Fiorentino TV, Succurro E, Andreozzi F, Sciacqua A, Perticone F, Sesti G.

Diabetes Metab Res Rev. 2019 Feb;35(2):e3096. doi: 10.1002/dmrr.3096. Epub 2018 Nov 20.

PMID:
30378248
16.

Response to Letter to the Editor: "One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes".

Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Perticone M, Hribal ML, Sciacqua A, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):676-677. doi: 10.1210/jc.2018-01824. No abstract available.

PMID:
30239916
17.

Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study.

Fiorentino TV, Succurro E, Arturi F, Giancotti A, Peronace C, Quirino A, Sesti F, Andreozzi F, Hribal ML, Perticone F, Focà A, Sesti G.

Sci Rep. 2018 Sep 11;8(1):13616. doi: 10.1038/s41598-018-32108-8.

18.

The polymorphism rs35767 at IGF1 locus is associated with serum urate levels.

Mannino GC, Fuoco A, Marini MA, Spiga R, Di Fatta C, Mancuso E, Perticone F, Andreozzi F, Sesti G.

Sci Rep. 2018 Aug 16;8(1):12255. doi: 10.1038/s41598-018-29665-3.

19.

One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes.

Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Perticone M, Hribal ML, Sciacqua A, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3131-3143. doi: 10.1210/jc.2018-00468. Review.

PMID:
30020454
20.

Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals.

Fiorentino TV, Sesti F, Succurro E, Pedace E, Andreozzi F, Sciacqua A, Hribal ML, Perticone F, Sesti G.

Acta Diabetol. 2018 Aug;55(8):835-842. doi: 10.1007/s00592-018-1153-8. Epub 2018 May 17.

PMID:
29774469
21.

Uric Acid Impairs Insulin Signaling by Promoting Enpp1 Binding to Insulin Receptor in Human Umbilical Vein Endothelial Cells.

Tassone EJ, Cimellaro A, Perticone M, Hribal ML, Sciacqua A, Andreozzi F, Sesti G, Perticone F.

Front Endocrinol (Lausanne). 2018 Mar 26;9:98. doi: 10.3389/fendo.2018.00098. eCollection 2018.

22.

Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction.

Fiorentino TV, Marini MA, Succurro E, Sciacqua A, Andreozzi F, Perticone F, Sesti G.

Oncotarget. 2017 Jun 19;8(45):79576-79586. doi: 10.18632/oncotarget.18572. eCollection 2017 Oct 3.

23.

No effect on the short-term of a decrease in blood viscosity on insulin resistance.

Gnasso A, Cacia M, Cortese C, Succurro E, Andreozzi F, Carallo C, Irace C.

Clin Hemorheol Microcirc. 2018;68(1):45-50. doi: 10.3233/CH-170288.

PMID:
29036798
24.

Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals.

Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Sciacqua A, Hribal ML, Perticone F, Sesti G.

Diabetes Res Clin Pract. 2017 Dec;134:53-61. doi: 10.1016/j.diabres.2017.09.017. Epub 2017 Oct 6.

PMID:
28993156
25.

Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia.

Fiorentino TV, Suraci E, Arcidiacono GP, Cimellaro A, Mignogna C, Presta I, Andreozzi F, Hribal ML, Perticone F, Donato G, Luzza F, Sesti G.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):3979-3989. doi: 10.1210/jc.2017-00348.

PMID:
28938485
26.

Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials.

Monami M, Dicembrini I, Nreu B, Andreozzi F, Sesti G, Mannucci E.

Acta Diabetol. 2017 Dec;54(12):1101-1114. doi: 10.1007/s00592-017-1054-2. Epub 2017 Sep 20. Review.

PMID:
28932989
27.

Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.

Dicembrini I, Nreu B, Scatena A, Andreozzi F, Sesti G, Mannucci E, Monami M.

Acta Diabetol. 2017 Nov;54(11):1069-1071. doi: 10.1007/s00592-017-1049-z.

PMID:
28924916
28.

Insulin-like growth factor-1 is a negative modulator of glucagon secretion.

Mancuso E, Mannino GC, Fatta CD, Fuoco A, Spiga R, Andreozzi F, Sesti G.

Oncotarget. 2017 Jun 16;8(31):51719-51732. doi: 10.18632/oncotarget.18514. eCollection 2017 Aug 1.

29.

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.

Dicembrini I, Nreu B, Scatena A, Andreozzi F, Sesti G, Mannucci E, Monami M.

Acta Diabetol. 2017 Oct;54(10):933-941. doi: 10.1007/s00592-017-1031-9. Epub 2017 Jul 27. Review. Erratum in: Acta Diabetol. 2017 Sep 19;:.

PMID:
28748377
30.

Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals.

Andreozzi F, Mannino GC, Mancuso E, Spiga R, Perticone F, Sesti G.

PLoS One. 2017 Jun 21;12(6):e0179834. doi: 10.1371/journal.pone.0179834. eCollection 2017.

31.

Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.

Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, Perticone F, Sesti G.

Acta Diabetol. 2017 Aug;54(8):775-784. doi: 10.1007/s00592-017-1004-z. Epub 2017 Jun 2.

PMID:
28577138
32.

Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials.

Monami M, Nreu B, Scatena A, Giannini S, Andreozzi F, Sesti G, Mannucci E.

J Endocrinol Invest. 2017 Nov;40(11):1251-1258. doi: 10.1007/s40618-017-0698-7. Epub 2017 May 31. Review.

PMID:
28569363
33.

Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels.

Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Succurro E, Sciacqua A, Perticone F, Sesti G.

Nutr Metab Cardiovasc Dis. 2017 Jul;27(7):601-608. doi: 10.1016/j.numecd.2017.04.001. Epub 2017 Apr 21.

PMID:
28511905
34.

Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials.

Monami M, Zannoni S, Pala L, Silverii A, Andreozzi F, Sesti G, Mannucci E.

Int J Cardiol. 2017 Aug 1;240:414-421. doi: 10.1016/j.ijcard.2017.03.163. Epub 2017 May 5.

PMID:
28501352
35.

Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.

Marini MA, Fiorentino TV, Succurro E, Pedace E, Andreozzi F, Sciacqua A, Perticone F, Sesti G.

PLoS One. 2017 Apr 20;12(4):e0175547. doi: 10.1371/journal.pone.0175547. eCollection 2017.

36.

A polymorphism at IGF1 locus is associated with anemia.

Marini MA, Mannino GC, Fiorentino TV, Andreozzi F, Perticone F, Sesti G.

Oncotarget. 2017 May 16;8(20):32398-32406. doi: 10.18632/oncotarget.16132.

37.

Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells.

Spiga R, Marini MA, Mancuso E, Di Fatta C, Fuoco A, Perticone F, Andreozzi F, Mannino GC, Sesti G.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1241-1249. doi: 10.1161/ATVBAHA.117.309128. Epub 2017 Apr 13.

PMID:
28408375
38.

Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.

Monami M, Nreu B, Scatena A, Cresci B, Andreozzi F, Sesti G, Mannucci E.

Diabetes Obes Metab. 2017 Sep;19(9):1233-1241. doi: 10.1111/dom.12926. Epub 2017 Jun 20.

PMID:
28244632
39.

Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.

Palleria C, Leo A, Andreozzi F, Citraro R, Iannone M, Spiga R, Sesti G, Constanti A, De Sarro G, Arturi F, Russo E.

Behav Brain Res. 2017 Mar 15;321:157-169. doi: 10.1016/j.bbr.2017.01.004. Epub 2017 Jan 3.

PMID:
28062257
40.

Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.

Andreozzi F, Mannino GC, Perticone M, Perticone F, Sesti G.

Atherosclerosis. 2017 Jan;256:15-20. doi: 10.1016/j.atherosclerosis.2016.11.020. Epub 2016 Nov 17.

PMID:
27940375
41.

The role of miR-190a in methylglyoxal-induced insulin resistance in endothelial cells.

Mirra P, Nigro C, Prevenzano I, Procopio T, Leone A, Raciti GA, Andreozzi F, Longo M, Fiory F, Beguinot F, Miele C.

Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):440-449. doi: 10.1016/j.bbadis.2016.11.018. Epub 2016 Nov 15.

42.

One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.

Fiorentino TV, Andreozzi F, Mannino GC, Pedace E, Perticone M, Sciacqua A, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2016 Nov;101(11):4030-4038. Epub 2016 Jul 26.

PMID:
27459528
43.

Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life study.

Del Prete S, Cennamo G, Leo L, Montella L, Vincenzi B, Biglietto M, Andreozzi F, Prudente A, Iodice P, Savastano C, Nappi A, Montesarchio V, Addeo R.

Future Oncol. 2017 Feb;13(5):415-423. doi: 10.2217/fon-2016-0421. Epub 2016 Oct 26.

PMID:
27780365
44.

One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden.

Fiorentino TV, Sesti F, Andreozzi F, Pedace E, Sciacqua A, Hribal ML, Perticone F, Sesti G.

Atherosclerosis. 2016 Oct;253:61-69. doi: 10.1016/j.atherosclerosis.2016.08.020. Epub 2016 Aug 25.

PMID:
27588935
45.

The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism.

Andreozzi F, Raciti GA, Nigro C, Mannino GC, Procopio T, Davalli AM, Beguinot F, Sesti G, Miele C, Folli F.

J Transl Med. 2016 Jul 30;14(1):229. doi: 10.1186/s12967-016-0985-7.

46.

Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions.

Fiorentino TV, Sesti F, Andreozzi F, Pedace E, Succurro E, Sciacqua A, Perticone F, Sesti G.

Nutr Metab Cardiovasc Dis. 2016 May;26(5):439-41. doi: 10.1016/j.numecd.2016.01.009. Epub 2016 Feb 3. No abstract available.

PMID:
27039961
47.

Response to the Letter: Comment to the letter by Marathe CS, Rayne CK, Jones KL, Horowitz M.

Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2016 Feb;101(2):L35. doi: 10.1210/jc.2015-4298. No abstract available.

PMID:
26840118
48.

PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases.

Hribal ML, Mancuso E, Spiga R, Mannino GC, Fiorentino TV, Andreozzi F, Sesti G.

Expert Opin Ther Targets. 2016 Jun;20(6):663-75. doi: 10.1517/14728222.2016.1130822. Epub 2016 Jan 11. Review.

PMID:
26652182
49.

One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.

Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2015 Oct;100(10):3744-51. doi: 10.1210/jc.2015-2573. Epub 2015 Aug 14.

PMID:
26274345
50.

Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.

Prudente S, Bailetti D, Mendonca C, Mannino GC, Fontana A, Andreozzi F, Hastings T, Mercuri L, Alberico F, Basile G, Copetti M, Sesti G, Doria A, Trischitta V.

Atherosclerosis. 2015 Sep;242(1):334-9. doi: 10.1016/j.atherosclerosis.2015.07.030. Epub 2015 Jul 17.

Supplemental Content

Loading ...
Support Center